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Our understanding of the global molecular
epidemiology of HIV-1 infections has improved
substantially in recent years. Remarkable anti-
genic diversity, especially in the viral envelope,
has emerged among HIV isolates worldwide (1).
As the HIV/AIDS pandemic grows, viral strains
are becoming more geographically dispersed,
and the simultaneous presence of multiple
subtypes in a given region is now common (2).
Mixed infections and recombinants involving
sequences of distinct HIV-1 subtypes (mosaics)
are being recognized, but their prevalence and
effect on the pandemic have not been fully
evaluated (3). Consequently, the distribution of
dual infections and mosaic viruses among
different populations and the changes of this
distribution over time are still relatively
unknown. In addition, scientists are increas-
ingly interested in possible differences in the
transmission, epidemiologic patterns, and natu-
ral history of HIV-1 infections caused by more
than one viral subtype and recombinant
genomes. Finally, the efficacy of HIV-1 vaccines,
primarily developed against subtype B viruses,
may differ against more divergent recombinant
variants and mixed infections of distinct HIV-1
subtypes. Such knowledge is vital to understand-
ing the relevant role of mixed infections as a
prerequisite for recombination and could be
applied immediately in molecular epidemiology
and immunotherapy.
Studies using convenience samples first
documented mixed infections caused by viruses
of subtypes B and E in Thailand (4). Subsequently,
such studies have identified cases of dual
infections with subtypes B, F, C, and D in Brazil
(5-7), B and F in Puerto Rico (8), A and C in
Rwanda (9), and triple HIV-1 infection with
groups O and M of different clades in a single
Cameroonian AIDS patient (10). In addition,
potential dual infections have been detected by
molecular screening assays among HIV-1 infected
populations in Uganda and Kenya, where subtypes
A and D coexist (11). The consequences of HIV-1
mixed infections may profoundly influence the
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dynamic of the pandemic through altered patterns
of viral transmission and pathogenesis. More-
over, the resulting genetic variation may lead to
the emergence of new HIV variants, including
those with altered antigenicity and reduced
sensitivity to detection by current diagnostic
assays. The global emergence of such variants is
exemplified in the impact of two HIV-1
recombinants of subtypes A/E and G/A on
epidemics in Thailand and in certain parts of
Central Africa, respectively (1,12-14). Interest-
ingly, the presumptive parental subtypes E and
G have not been identified.
Because Brazil has been selected as a World
Health Organization field site for HIV-1 vaccine
evaluation programs, priority has been given to
extensive molecular examination of the preva-
lence and genetic diversity of HIV-1 strains
circulating in the country. By November 1997,
116,277 AIDS cases had been reported to the
Brazilian AIDS Control Program of the Ministry
of Health (15). The 293 HIV-1 strains that have
been molecularly characterized document that,
although four HIV-1 subtypesB, F, C, and D
are circulating in Brazil, only subtypes B and F
are common (16-21). Moreover, five HIV-1 dual
infections were identified in 21 HIV-infected
patients during testing of molecular techniques
that would discriminate between HIV-1 infec-
tions caused by single and multiple subtypes (5-
7). Also, two cases of B/F recombinants have been
found accidentally through sequence analysis of
the env region (22). These data only indicate
the potential for dual and recombinant
infections in Brazil, where multiple subtypes
circulate; they cannot, however, be used to
assess the frequency of these infections among
the HIV-infected population. In this study, we
evaluated the proportion of HIV-1 dual and
recombinant infections among 79 patients
enrolled in a prospective clinical cohort study
in Rio de Janeiro (an area where HIV-1
subtypes B and F are common).
The Study
Population
Part of an ongoing prospective clinical cohort
study established in 1991 by the AIDS program
of the Federal University of Rio de Janeiro, the
HIV-1-infected patients have been continuously
enrolled in the cohort for consultation, treat-
ment, evaluation of different clinical parameters
during the progression of the disease, and
assessment of the genetic variation of HIV-1
strains (23). With informed consent, blood
samples were obtained from the 79 patients, who
consecutively attended the clinic between
October and December 1994. For the purposes of
this study, samples collected in 1994 were
compared as needed, and follow-up specimens
were collected 1 year later. The clinical profile of
patients was based on the medical evaluation at
the time of blood collection. Because the patients
were randomly selected, the findings presented
in this article likely reflect the trends in the HIV/
AIDS epidemic in the Rio de Janeiro area. Epi
Info, Version 6 program (CDC, Atlanta, GA,
USA) was used to calculate frequencies, means,
and analyses of variance of demographic
information, clinical stages, and laboratory
parameters.
Design
To investigate the proportion of mixed
infections, we must distinguish between those
involving two or more distinct HIV-1 strains and
infection with a single intersubtype recombinant
strain. By definition, the mixed infection occurs
when multiple phylogenetically distinct copies of
the same gene representing different viral
genomes are present within one patient (24). In
contrast, in the mosaic strain, different viral
regions within the same genome are classified by
phylogenetic analysis into different subtypes (3).
Potential HIV-1 mixed infections involving
distinct HIV-1 variants were segregated from
single infections caused by only one subtype by
using a restriction fragment length polymor-
phism (RFLP) screening assay of the prt gene
(5,7). The restriction map profiles of the viral prt
allow the segregation of HIV-1 strains to
subtypes A, B, C, D, and F (Figure 1A). AluI
digestion patterns separate subtypes A, C, and F
from subtypes B and D. Sequential restriction
analysis of prt using HinfI, BclI, and ScaI
restriction enzymes further differentiates among
these two subtype groups. The simultaneous
occurrence of more than one digestion pattern
indicates a potential mixed infection (Figure 1B).
We selected recombinants among RFLP-subtyped
single infections by additionally subtyping the
C2-V3  env region with the heteroduplex mobility
assay (25). Subtype discrepancies between prt
and  env regions were considered potential HIV-1
recombinants. All potential multiple infections67 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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and recombinants were analyzed by sequence
analysis. The search for recombinants was
further expanded by sequence analysis of the
entire p17 gag or a 311-bp of the p24 gag
fragment or both among preselected prt-env
recombinants, all prt-env subtype F, and some
prt-env subtype B viruses.
Polymerase Chain Reaction (PCR)
Uncultured or cultured peripheral blood
mononuclear cells from patients were used for
nested-PCR of the entire HIV-1 protease gene
(prt, 297-bp), p24 gag fragment (311-bp), and C2-
V3 domain of env (565-bp) (6,7).  The outer
primers for amplification of a 717-bp gag
fragment spanning the entire 17 gag region and
a 311-bp of p24 gag were LTRF:
5'GGGCTAATTTGGTCAAAAAGAAG; nucleotide
position: 6-28, HIV-1MN, and P24RA:
5'ATGTCACTTCCCCTTGGTTCT; nucleotide po-
sition: 1482-1502. The inner primers were P17F:
5'GCAAGAGGCGAGGGGCAGCAGCCG; nucle-
otide position: 716-739, and P17R:
5'CCCATTCTGCAGCTTCATTGA; nucleotide po-
sition: 1413-1433. The outer primers for
amplification of a 1,444-bp fragment from p24
gag to the reverse transcriptase region were
P24F1: 5'ATAGAGGAAGAGCAAAACAAAA;
nucleotide position: 1,099 to 1,120, and MOPR1:
5'AAAATTGGAGTATTGTATGGATT; nucleotide
position: 2,724 to 2,746. The inner primers were
P24FA: 5'CAAAATTACCCTATAGTGCA; nucle-
otide position: 1,177 to 1,196, and MOPR2:
5'GGTCCATCCATTCCTGGTTT; nucleotide po-
sition: 2,601 to 2,620. PCR conditions were the
same for amplification of all viral regions (7).
Sensitivity of Detection of Dual Infections
To determine the sensitivity of detection of
dual infections by the RFLP assay, we mixed 5,
10, 25, 50, and 100 copies of subtypes B and F
cloned proviral DNA in equal proportions or in
ratios 1:2, 1:4, 1:10, and 1:20 for nested PCR
amplification of prt (Table 1). For each
Figure 1. Differentiation between single (A) and dual
(B) HIV-1 infections by the restriction fragment
length polymorphism analysis of the polymerase
chain reactionamplified prt. A: Three AluI digestion
patterns represent subtypes A, C, and F (pattern 1)
and subtypes B and D (patterns 2 and 3); two HinfI
patterns represent subtypes D (pattern 1) and B
(pattern 2); two BclI patterns represent subtypes F
(patterns 1) and A and C (pattern 2); two ScaI
patterns represent subtypes A (pattern 1) and C
(pattern 2). B: Two AluI digestion patterns (1 and 2)
in the dually infected patient with HIV-1 subtypes F
and B; two HinfI patterns (1 and 2) in the patient
infected with subtypes B and D viruses.
Table 1. Sensitivity of detection of HIV-1 dual infections
caused by viruses of subtypes B and F
 No. of viral No. of AluI digestion
   subtypes Ratio experi- patterns of prt
  F B F:B ments B F B&F
100 100   1:1 1  -  - +
  50   50   1:1 4  -  - +
  25   25   1:1 4  - + (1) + (3)
  10   10   1:1 4  -  - +
    5     5   1:1 4  - + (3) + (1)
100     5 20:1 2  - + (1) + (1)
100   10 10:1 2  - + (1) + (1)
100   25   4:1 2  - +  -
100   50   2:1 2  -  - +
    5 100   1:20 1  -  - +
  10 100   1:10 1  -  - +
  25 100   1:4 1  -  - +
  50 100   1:2 1  -  - +
100     0 3  - +  -
  50     0 3  - +  -
  25     0 3  - +  -
  10     0 3  - +  -
    5     0 2  - +  -
    0 100 3 +  -  -
    0   50 2 +  -  -
    0   25 3 +  -  -
    0   10 3 +  -  -
    0     5 3 +  -  -
Absence (-) and presence (+) of AluI digestion pattern of prt
characteristic for subtype B, subtype F, and combination of
subtypes B and F (Fig. 1). The cloned proviral DNA of HIV-1
subtypes B and F spanning a 1444-bp fragment from p24 gag to
rt was used for the nested PCR amplification of prt. Amplified
products were digested with AluI restriction enzyme, and the
presence of two digestion patterns was analyzed on a 10%
polyacrylamide gel by ethidium-bromide staining.68 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
Research
combination, one to four independent PCR
reactions were run. The simultaneous amplifica-
tion of the viral prt of subtypes B and F was
evaluated by the RFLP assay. PCR controls
included DNA templates of single HIV-1 subtypes.
Cloning, Sequencing, and Phylogenetic
Analysis
The PCR-amplified proviral prt sequences
from potential dual infections were cloned by
using the Original TA Cloning Kit (Invitrogen,
Carlsbad, CA, USA). DNA from 30 clones of each
specimen was screened for distinct HIV-1
sequences by the RFLP assay (7). Double-
stranded viral DNA from selected clones or from
direct PCR-amplified prt, p17 and p24 gag, and
C2-V3 env products was cycle-sequenced in both
directions with fluorescent dyelabeled sequenc-
ing terminators (26). Sequencing reactions were
run in an automated DNA sequencer (Applied
Biosystems, Foster City, CA, USA). The sequences
were aligned by the CLUSTAL multiple
sequence alignment program (27). After gaps
were eliminated, the aligned sequences were
analyzed by the maximum likelihood method,
with the fastDNAml program, which uses
randomized data input and global rearrange-
ment (28). Additionally, the neighbor joining
method (PHYLIP package version 3.5c [29]) was
used, with or without bootstrapping. The stability
of the trees topology was tested by pruning
(removing one sequence from the alignment and
rerunning the phylogenetic analysis). The SIV-cpz
sequences (GenBank accession no. X52154) were
used as outgroups. HIV-1 sequences generated in
this study have been submitted to GenBank.
Results
Detection of Mixed Infections
RFLP analysis of the prt gene showed the
simultaneous presence of two different digestion
patterns in specimens from 10 of 79 patients. A
complex pattern composed of elements of AluI
patterns #1 (subtypes A, C, or F) and #2
(subtypes B or D) was identified in nine patients,
and a combination of two HinfI digestion
patterns (subtypes B and D) was found in one
patient (Figure 1B). These data suggest that
each of 10 patients could be infected with
multiple distinct HIV-1 subtypes. The remaining
69 samples were classified as single infections
caused by viruses of prt subtypes B (59) and F (10).
The PCR-amplified viral prt products from
these 10 patients were cloned and sequenced to
confirm the presence of mixed infections.
Sequence analysis showed the simultaneous
presence of two distinct HIV-1 variants in only
three patients: BR45, BR62, and BR83. The
nucleotide divergence between the two prt
sequences within the patients was 6.8% for
BR45, 7.4% for BR62, and 7.1% for BR83,
indicating two distinct HIV-1 variants in each of
these patients (6). Phylogenetic analysis con-
firmed these findings and demonstrated that the
divergent HIV-1 prt sequences segregated into
subtypes B and F (BR45), subtypes D and F
(BR62), and subtypes B and D (BR83) (Figure
2a). In the remaining seven specimens, the
observed RFLP results were consequences of
either point mutations in AluI restriction site
(five cases) or G A hypermutation (two cases),
which occurred across one of the sequences
within each specimen and destroyed the defining
AluI sites. These changes in AluI restriction sites
gave rise to genetically distinct quasispecies
within the patients but did not represent distinct
subtypes, as further confirmed by phylogenetic
analysis (e.g., BR55-1 and BR55-2, and BR99-1
and BR99-2 in Figure 2a). Thus, despite the
presence of mixed AluI digestion patterns in
these seven specimens, they were classified as
single infections of subtype B variants.
To address the issue of potential laboratory
contamination, we collected repeat blood
samples from dually infected patients approxi-
mately 1 year later and processed them on
separate occasions. (Blood was unlikely to be
contaminated during collection because a
disposable vacutainer system was used to obtain
each blood sample.) The sequence data from the
first and second blood samples of each person
showed a 98% to 99% similarity. Also, the viral
sequences from these patients were distinct from
those of laboratory strains (Figure 2a; 855M,
8,986, and 9,001) commonly used as standards.
Sensitivity of Detection of Dual Infections
To investigate the sensitivity of the RFLP
screening method, we performed reconstruction
experiments, in which two distinct viral DNA
templates of subtypes B and F were analyzed in
the same reaction mixture (Table 1). When equal
proportions of 10 to 100 HIV-1 DNA template
copies were used for prt amplification, two viral
subtypes could be simultaneously detected in all69 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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but one of 19 experiments). However, when five
or fewer copies of each viral subtype were used,
two subtypes were identified in only one of four
assays; in the remaining three assays either
subtype B or subtype F amplicons, but not both,
were found. Similarly, in experiments contain-
ing varying proportions of subtypes B and F
DNA templates, the simultaneous presence of
two viral subtypes could be detected in only 8
(66%) of 12 experiments. In comparison, 5 to
100 copies of a single viral subtype (B or F)
were routinely amplified and identified in all
control reactions.
Detection of Intersubtype HIV-1 Recombinants
Parallel RFLP/heteroduplex mobility assay
screening for HIV-1 subtypes in the prt and env
regions identified two potential recombinants
among 76 single infections. Subtype F prt and
subtype B env were found in both specimens
BR43 and BR60 during this initial screening.
The remaining specimens were classified into
subtypes F (n = 8) and B (n = 66) in both prt and
env regions. These prt-env potential recombi-
nants, all subtype F specimens, and eight selected
subtype B samples were further evaluated by
sequence analysis, which confirmed the results of
the screening assays (Figure 2a, 2b).
Figure 2. Phylogenetic classification of HIV-1 sequences from Brazilian patients (denoted with BR prefix).
The trees were constructed on the basis of DNA sequences of prt (a), env (b),  gag-p24 (c), and gag-p17 (d)
by the neighbor-joining method. Numbers at the branch nodes connected with subtypes indicate bootstrap
values. An arrow indicates dually infected specimens; an asterisk shows viral sequences, which clustered
into different lineages depending on which parts of viral genome were analyzed; ! represents hypermutated
sequences; ? represents unclassified subtype of p24 gag sequences. The distinct HIV-1 subtypes are
delineated. The scale bar indicates an evolutionary distance of 0.10 nucleotides per position in the
sequence. Vertical distances are for clarity only. GenBank accession numbers: prt [AF099155-
99171;AF079986-79989;AF079991; and AF079994-79996]; env [AF113560-113576]; p17gag [AF115443-
115451]; p24gag [AF115780-115797].70 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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The search for the HIV-1 recombinant
genome in these 18 samples was further
expanded to the gag region. Mosaic sequences of
subtypes B and F were found within the p17 or
p24 gag (Table 2, Figure 2, discussion below) in
four prt-env subtype F variants (BR46, BR57,
BR59, and BR97). Similarly, in one of two prt-env
recombinants (BR60), the gag sequences had a
mosaic pattern. In contrast, the p24 gag
sequences of eight prt-env subtype B specimens
were homogeneous and also classified as subtype
B (Figure 2). Taken together, the comparative
molecular analysis of gag, pol, and env regions
allowed the identification of six specimens that
carried HIV-1 recombinant genomes, represent-




The potential crossover breakpoints within
717-bp of the p17-p24 gag mosaic sequences were
examined by comparison with nucleotide
signature patterns characteristic for subtypes B
and F viruses (Figure 3). We performed
comparative analyses with aligned DNA se-
quences of recombinants (BR57, BR59, BR60,
and BR97), subtype B (MN and BR43), and
subtype F variants (BR41, BR54, BR58, and
BR112). This analysis confirmed an intragene
recombination within p24 gag in specimens
BR57, BR60, and BR97a finding consistent
with our failure to phylogenetically assign these
gag sequences to any known subtype (Figure 2c).
The putative breakpoints within the
intragene recombinant sequences were located
between nucleotides 97 and 137 in sample BR57
and between nucleotides 173 and 213 in BR60
and BR97 (Figure 3). The exact breakpoint
position could not be determined because of
extensive sequence homology between subtypes
B and F in this viral region. This analysis also
revealed putative crossover breakpoints for
variants BR57 and BR59 in proximity to the
coding region for the p17-p24 protein-processing
site. The potential breakpoints between the
second half of gag and the beginning of pol region
in variants BR43, BR46, and BR59 are being
investigated.
To examine the possibility of in vitro
recombination during PCR amplification (30), we
performed PCR amplification of the long
fragments covering the gag and prt area in the
endpoint- diluted lysates (31). To ensure that
endpoint PCR products were amplified from
single copy templates, we used samples only
from dilutions at which 1 of 10 PCR
amplifications were productive for further
sequence analysis. The comparative analysis of
the entire p17 gag, p24 gag, and prt sequences
demonstrated 98% homology between the
undiluted and diluted lysatesstrong evidence
that the recombinant sequences were not a
result of the PCR amplification process.
Epidemiologic and Clinical Characteristics
The mean ages of patients infected with HIV-
1 of single subtype B or F were not different from
those with dual or recombinant infections (p =
0.77) (Table 3). In addition, the patients did not
differ significantly by gender, risk group, and
clinical stage of disease (p = 0.44 to p = 0.48). The
patients infected with HIV-1 subtype B (403) and
subtype F (854) did, however, differ (p = 0.04) by
mean CD4 counts. Although dates of
seroconversion were not known for all patients,
the earliest HIV-positive results were reported
among patients infected with subtype B (in
agreement with previous observations that the
spread of subtype B viruses occurred earlier than
other HIV-1 subtypes in Brazil [16,17]), which
might explain the difference in CD4 counts.
Table 2. p17/p24 gag, prt, and C2-V3 genetic subtyping
of HIV-1 DNA sequencesa from peripheral blood
mononuclear cells collected from 18 patients in Rio de
Janeiro
Genotypes
Specimen No. gag p17 gag p24 prt C2-V3
Group 1b 8 N D c B B  B
Group 2d 4  F F F  F
(BR46) (NAe) (B) (F) (F)
(BR59) (F) (B) (F) (F)
(BR57) (F) (B/F) (F) (F)
(BR97) (B) (B/F) (F) (F)
(BR60) (B) (B/F) (F) (B)
(BR43) (B) (B) (F) (B)
aRecombinant specimens are shown in parentheses; B/F 
mosaic structure within a 311-bp of the p24 gag fragment
consisting of subtypes B and F sequences.
bGroup 1: BR34, BR52, BR55, BR64, BR65, BR71, BR75, and
BR92.
cND=not done.
dGroup 2: BR41, BR54, BR58, and BR112.
eNA = not available due to negative PCR.71 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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Figure 3. Analysis of the putative recombination within the gag region. The aligned sequences were classified into
subtype B, subtype F, and recombinant subtype B/F on the basis of linearity of subtype assignment for the p17-p24
gag region. Asterisks show characteristic nucleotide patterns for subtypes B and F sequences; dots represent
nucleotides homologous to the MN gag sequence; dashes indicate gaps introduced to maintain the alignment; and
arrows indicate the potential recombination regions within the p24 gag fragment. The nucleotide position is marked.72 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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Conclusions
HIV-1 infections caused by dual and
intersubtype-recombinant genome may be rela-
tively common among HIV-1-infected Brazilians.
Using both heteroduplex mobility assay and
RFLP screening methods, as well as sequencing,
we identified three dual (3.8%) and six
recombinant (7.6%) infections involving distinct
viral subtypes among 79 HIV-1-infected persons
from Rio de Janeiro.
We chose viral prt to screen for dual
infections because this highly conserved region
provides the best opportunity for simultaneous
amplification of distinct HIV-1 variants in the
same PCR reaction. Proviral prt sequences can
be routinely amplified from approximately 95%
of all analyzed seropositive samples collected
from the Americas, Asia, Africa, and Europe
(data not shown). Moreover, the RFLP assay of
the prt gene is convenient for screening a large
number of samples (5). The detection of B/F, B/D,
and F/D dual infections is in agreement with our
1993 study among patients from the same Rio de
Janeiro cohort, which showed five dual HIV-1
infections involving subtypes F and B (one case),
F and D (one case), and B and C (three cases of
familial clustering) among 21 HIV-infected
persons (5-7). Interestingly, dual infections
involving HIV-1 subtype D continue to be
detected in patients from Rio de Janeiro, an area
with a high predominance of HIV-1 subtypes B
and F, but rare subtype D, single infections.
Because retrospective specimens (peripheral
blood mononuclear cells) were not available for
these patients, we could not confirm whether the
acquisition of mixed strains was sequential
(superinfection) or simultaneous. However,
combination of subtypes F or B with rare subtype
D viruses among some dual infections may
suggest that in these cases two viral strains
might be acquired through cotransmission
rather than through superinfection.
All naturally occurring HIV-1 dual infections
are likely not detected by current methods. First,
quantitative differences in two distinct viral
DNA templates in the sample can lead to
selective PCR amplification of only one subtype.
Second, despite targeting conserved genes such
as prt, some divergent viral strains may escape
PCR amplification because of primer mis-
matches. Finally, a single nucleotide mutation in
the endonuclease restriction site can abrogate
the recognition pattern and distort detection of
dual infections in the RFLP analysis. These
observations suggest that the rate of HIV-1
mixed infections within this Brazilian cohort
might be even higher than 4%. Our previous
findings of five dual infections among 21 patients
from the same cohort support this assumption. If
Table 3. Characteristics of the study population
Dual Recombinant
infection infection Subtype B Subtype F
Characteristic n=3 n=6 n=66 n=4
Gender (Female/male)         1/2           3/3        24/42           3/1
Mean age in years (range)    36 (30-44)      34 (25-45)     37 (23-60)     34 (26-43)
Clinical stagea
     1          3             5           29            4
     2           -             1           17             -
     3           -              -           14             -
     4           -              -             6             -
Mean CD4 cells (range) 527  (404-743) 484 (190-821) 403 (59-1281)b 823 (570-1270)
Years of 1st serologic tests
     1985-1987           -              -             2             -
     1988-1991          2             2           30            2
     1992-1994          1             4           34            2
Heterosexual          2             5           27            4
Homosexual          1              -           19             -
Bisexual           -              -             8             -
Blood transfusion recipient           -              -             3             -
Intravenous drug user           -              -             1             -
Multiple factors           -             1             2             -
Unknown           -              -             6             -
aWHO staging system [32].
bBased on data available for 54 patients.73 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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we take into account these five cases, the
percentage of mixed infections caused by viruses
of distinct subtypes circulating between 1993
and 1994 among 100 patients analyzed from this
Rio de Janeiro cohort would increase to 8%.
The potential underestimate of mixed
infections is highlighted by the additional
detection of 6 (7.6%) distinct recombinants
within the cohort. This finding is consistent with
the estimated 5% to 10% intersubtype mosaics
among HIV-1 genomes in the Los Alamos
database (3). Interestingly, all recombinant or
mosaic genomes described in this report involved
only subtypes B and F viral regions, although
dual infections caused by other subtypes were
also circulating in this cohort. Moreover, our
results indicate that recombination between gag
and  pol ( prt) regions is more frequent than
between  pol and env and lead to speculation that
such stable B/F mosaics have selective advan-
tage. Such observations support the assumption
that recombination within the gag gene occurs
more often than within other viral regions (33)
and emphasize the need for rapid subtyping
methods specific to the gag region.
To investigate the potential impact of dual
and recombinant infections on the  clinical status
of patients, we compared the clinical and
demographic characteristics of these patients
with those of patients infected with one
nonrecombinant viral subtype. Epidemiologic
information for all 79 patients was available only
at the first draw of blood. Although the results
did not show significant differences between the
two groups, the possibility of differences exists.
Our findings provide the first baseline
measure of the range of HIV variability in Rio de
Janeiro from 1993 to 1994 and the proportion of
dual and recombinant infections among the HIV-
infected Brazilian population. Future systematic
molecular epidemiologic surveys of HIV hetero-
geneity in Rio de Janeiro may show the potential
changes in the molecular profile of the HIV/AIDS
epidemic over time; the laboratory tools we used
to identify single, dual, and recombinant
infections may be useful in such investigations.
Nevertheless, our study on genetic variation of
HIV-1 subtypes among blood donors from the
state of Rio de Janeiro documented the presence
of mosaic viruses of subtypes B and F and
subtypes B and D in blood units collected in 1996
(34). Moreover, recent genetic analysis of viral
strains collected in 1997 from HIV-1-infected
patients living in Manaus (a city in Brazils
Amazon region) showed the presence of dual
infections and recombinants caused by subtypes
B and F viruses (A. Tanuri, pers. comm.).
Therefore, these data indicate that the heterogenic
pattern of HIV-1 infections, first observed in Rio
de Janeiro, also exists in other regions of Brazil.
Our findings indicate that mixed infections
and mosaic viruses may be more common in
worldwide epidemics than previously thought
and, therefore, may provide a basis for
developing AIDS vaccines and predicting the
global evolution of HIV.
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